Table 1 Basic patient characteristics
From: Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
Variable | N = 100 |
|---|---|
Age (mean ± SD) (year) | 65.1 ± 11.2 |
BMI (m2/kg) | 23.56 ± 5.93 |
Gender | |
Female | 17 (17.0%) |
Male | 83 (83.0%) |
ASA | |
1 | 34 (34.0%) |
2 | 57 (57.0%) |
≥ 3 | 9 (9.0%) |
pT stage | |
T2 | 50 (50.0%) |
T3 | 42 (42.0%) |
T4 | 8 (8.0%) |
LVI | 42 (42.0%) |
CIS | 34 (34.0%) |
N stage | |
N0 | 80 (80.0%) |
N1 | 7 (7.0%) |
N2 | 8 (8.0%) |
N3 | 5 (5.0%) |
LND range | |
Standard | 36 (36.0%) |
Extend | 64 (64.0%) |
Removed LN | 14.1 ± 12.9 |
Positive LN | 1.0 ± 2.8 |
Recurrence | 31 (31.0%) |
Mortality | 59 (59.0%) |
Cancer related mortality | 32 (32.0%) |